{"id":3150,"date":"2010-03-13T18:38:00","date_gmt":"2010-03-14T00:38:00","guid":{"rendered":"http:\/\/medicinainterna.com.mx\/2010\/03\/13\/criterios-para-inicio-de-terapia-arv-4"},"modified":"2010-03-13T18:38:00","modified_gmt":"2010-03-14T00:38:00","slug":"criterios-para-inicio-de-terapia-arv-4","status":"publish","type":"post","link":"https:\/\/medicinainterna.com.mx\/?p=3150","title":{"rendered":"Criterios para inicio de terapia ARV."},"content":{"rendered":"
\u00a0<\/h5>\n\n\n\n\n\n\n\n\n\n\n
\n

CATEGOR\u00cdA CL\u00cdNICA.<\/b><\/p>\n<\/td>\n

\n

CD4<\/b><\/p>\n<\/td>\n

\n

CV<\/b><\/p>\n<\/td>\n

\n

RECOMENDACI\u00d3N.<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

Infecci\u00f3n retroviral aguda o < 6 meses de seroconversi\u00f3n.<\/p>\n<\/td>\n

\n

Cifra indistinta<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n

\n

Enviar a hospital de 3er nivel para evaluar tratamiento protocolizado.<\/p>\n<\/td>\n<\/tr>\n

\n

Infecci\u00f3n Cr\u00f3nica Asintom\u00e1tica.<\/p>\n<\/td>\n

\n

> 350<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n

\n

Diferir tratamiento evaluar cada 3-4 meses con nueva cuenta de CD4<\/p>\n<\/td>\n<\/tr>\n

\n

200 \u2013 350<\/p>\n<\/td>\n

\n

<No disponible<\/p>\n<\/td>\n

\n

Tratamiento<\/p>\n<\/td>\n<\/tr>\n

\n

200 \u2013 350<\/p>\n<\/td>\n

\n

< 100,000 copias de ARN viral(1).<\/p>\n<\/td>\n

\n

Individualizar vigilar cada 3-4 meses con CD4<\/p>\n<\/td>\n<\/tr>\n

\n

200 \u2013 350<\/p>\n<\/td>\n

\n

> 100,000 copias de ARN viral(1)<\/p>\n<\/td>\n

\n

Tratamiento<\/p>\n<\/td>\n<\/tr>\n

\n

< 200<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n

\n

Tratamiento<\/p>\n<\/td>\n<\/tr>\n

\n

Infecci\u00f3n cr\u00f3nica sintom\u00e1tica<\/p>\n<\/td>\n

\n

Cifra indistinta<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n

\n

Tratamiento<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

* es recomedable efectuar carga viral aunque no es indispensable para la toma de decisi\u00f3n.<\/p>\n

(1) Valores de acuerdo a la t\u00e9cnica de RT\/ PCR (Amplicor). No existe evidencia clara de los niveles recomendados para bDNA versi\u00f3n 3.0 u otras metodolog\u00edas.<\/p>\n

Fuente: Gu\u00eda de Manejo antirretroviral de las personas con VIH, Secretar\u00eda de Salud, Mexico 2007.<\/p>\n

<\/h4>\n

De acuerdo al Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antirretroviral agents in HIV-1 infected adults and adolescents.<\/p>\n

\u00b7 <\/sup>Puede ser iniciado en todos los pacientes con una historia de enfermedad definitoria de SIDA o con un conteo de CD4 <350 cel\/mm3<\/sup><\/h4>\n

\u00b7 Cifra indistinta de CD4 con las siguientes condiciones: embarazo, nefropat\u00eda asociada a VIH, hepatitis B.<\/h4>\n","protected":false},"excerpt":{"rendered":"

\u00a0 CATEGOR\u00cdA CL\u00cdNICA. CD4 CV RECOMENDACI\u00d3N. Infecci\u00f3n retroviral aguda o < 6 meses de seroconversi\u00f3n. Cifra indistinta * Enviar a hospital de 3er nivel para evaluar tratamiento protocolizado. Infecci\u00f3n Cr\u00f3nica Asintom\u00e1tica. > 350 * Diferir tratamiento evaluar cada 3-4 meses con nueva cuenta de CD4 200 \u2013 350 <No disponible Tratamiento 200 \u2013 350 < … Continue reading “Criterios para inicio de terapia ARV.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[11],"tags":[],"class_list":["post-3150","post","type-post","status-publish","format-standard","hentry","category-infectologia"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/3150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3150"}],"version-history":[{"count":0,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/3150\/revisions"}],"wp:attachment":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}